Antibacterial activity of cefpirome against clinically isolated strains in pediatric patients

Yoshitake Sato, Satoshi Iwata, Hironobu Akita, Yasuko Nitta, Katsuhito Nonoyama, Takao Yokota, Keisuke Sunakawa

Research output: Contribution to journalArticle

Abstract

The antibacterial activity of a new cephem, cefpirome, was evaluated in comparison with those of other antimicrobial agents against 425 aerobic Gram-positive and negative bacteria isolated from infections in pediatric patients. 1) As to Gram-positive cocci, cefpirome showed antibacterial activity equivalent or superior to those of existing cephems against streptococci, and similar activity to that of first-generation cephems against methicillin-sensitive Staphylococcus aureus and coagulase-negative streptococci. Against methicillin-resistant S. aureus, cefpirome showed antibacterial activity equivalent or superior to those of existing third-generation cephems. Against Enterococcus faecalis cefpirome showed comparatively good antibacterial activity among cephems, but was inferior to penicillins. 2) As to Gram-negative bacilli, cefpirome showed antibacterial activity equivalent or superior to existing third-generation cephems, and against Pseudomonas aeruginosa, its activity was almost equivalent to that of piperacillin though inferior to those of ceftazidime, aztreonam and imipenem.

Original languageEnglish
Pages (from-to)1020-1028
Number of pages9
JournalChemotherapy
Volume39
Issue number11
DOIs
Publication statusPublished - 1991 Jan 1

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology
  • Drug Discovery
  • Oncology

Cite this

Sato, Y., Iwata, S., Akita, H., Nitta, Y., Nonoyama, K., Yokota, T., & Sunakawa, K. (1991). Antibacterial activity of cefpirome against clinically isolated strains in pediatric patients. Chemotherapy, 39(11), 1020-1028. https://doi.org/10.11250/chemotherapy1953.39.1020